Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children

Pediatric Blood and Cancer

Volumn 52, Issue 5, 2009, Pages 626-630

  Alsultan, Abdulrahman ^a   Goldenberg, Neil A ^a   Kaiser, Nicole ^a   Graham, Douglas K ^a   Hays, Taru ^a  

^a CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

Children; Immunosuppressive therapy; Severe aplastic anemia; Tacrolimus

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DIPHENHYDRAMINE; LEUKOCYTE ANTIGEN; METHYLPREDNISOLONE; NYSTATIN; PARACETAMOL; PENTAMIDINE; PETHIDINE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; APLASTIC ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOLLOW UP; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; PATHOLOGY;

ADOLESCENT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63649161122     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21926     Document Type: Article

References (15)

1. Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Haematol 2008;15:162-168.
2. Scott LJ, McKeage K, Keam SJ, et al. Tacrolimus: A further update of its use in the management of organ transplantation. Drugs 2003; 63:1247-1297.
3. Ratanatharathorn V, Nash RA, Przepiorka D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood 1998;92:2303-2314.
4. Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation fromunrelated donors. Blood2000;96:2062-2068.
5. Haddad EM, McAlister VC, Renouf E, et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev (Online) 2006;4: CD005161.
6. Trompeter R, Filler G, Webb NJ, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol (Berlin, Germany) 2002;17:141 -149.
7. Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immuno- suppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999;18:336- 345.
8. Goldenberg NA, Graham DK, Liang X, et al. Successful treatment of severe aplastic anemia in children using standardized immuno- suppressive therapy with antithymocyte globulin and cyclosporine A. Pediatr Blood Cancer 2004;43:718-722.
9. Scheinberg P, Wu CO, Nunez O, et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr 2008;153:814-819.
10. FuhrerM, Rampf U, Baumann I, et al. Immunosuppressive therapy for aplastic anemia in children: A more severe disease predicts better survival. Blood 2005;106:2102-2104.
11. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000;96:2049-2054.
12. Saracco P, Quarello P, Iori AP, et al. Cyclosporin A response and dependence in children with acquired aplastic anaemia: A multi- centre retrospective study with long-term observation follow-up. Br J Haematol 2008;140:197-205.
13. Pongtanakul B, Das PK, Charpentier K, et al. Outcome ofchildren with aplastic anemia treated with immunosuppressive therapy. Pediatr Blood Cancer 2008;50:52-57.
14. Misra S, Moore TB, Ament ME, et al. Red cell aplasia in children on tacrolimus after liver transplantation. Transplantation 1998;65:575-577.
15. Dobrolet NC, Webber SA, Blatt J, etal. Hematologic abnormalities in children and young adults receiving tacrolimus-based immuno- suppression following cardiothoracic transplantation. Pediatr Transplant 2001;5:125-131.